Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007

Journal of Hospital Infection

Volumn 75, Issue 3, 2010, Pages 225-227

  Protonotariou, E ^a   Dimitroulia, E ^b   Pournaras, S ^c   Pitiriga, V ^b   Sofianou, D ^a   Tsakris, A ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Antimicrobial resistance; Enterococcus faecalis; Enterococcus faecium; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; BETA LACTAMASE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; OXAZOLIDINE DERIVATIVE; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENOTYPE; GREECE; NONHUMAN; PHENOTYPE; SPECIES DIFFERENTIATION; TREND STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HOSPITALS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS;

EID: 77953534350     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.12.007     Document Type: Article

References (17)

1. Mutnick A.H., Biedenbach D.J., Jones R.N. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2003, 46:63-68.
2. Quiñones D., Goñi P., Rubio M.C., Duran E., Gómez-Lus R. Enterococci spp. isolated from Cuba: species frequency of occurrence and antimicrobial susceptibility profile. Diagn Microbiol Infect Dis 2005, 51:63-67.
3. McDonald L.C. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006, 42(Suppl. 2):S65-S71.
4. Deshpande L.M., Fritsche T.R., Moet G.J., Biedenbach D.J., Jones R.N. Antimicrobial resistance and molecular epidemiology of vancomycin resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007, 58:163-170.
5. Tsakris A., Pournaras S., Douboyas J. Changes in antimicrobial resistance of enterococci isolated in Greece. J Antimicrob Chemother 1997, 40:735-737.
6. Facklam R.R., Collins M.D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989, 27:731-734.
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17 2008, CLSI, Wayne, PA.
8. Metzidie E., Manolis E.N., Pournaras S., Sofianou D., Tsakris A. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates. J Antimicrob Chemother 2006, 57:158-160.
9. Tsakris A., Woodford N., Pournaras S., Kaufmann M., Douboyas J. Apparent increased prevalence of high-level aminoglycoside-resistant Enterococcus durans resulting from false identification by a semiautomated software system. J Clin Microbiol 1998, 36:1419-1421.
10. Woodford N., Stigter J.M. Molecular investigation of glycopeptide resistance in gram-positive bacteria. Molecular bacteriology 1998, 579-615. Humana Press, Totowa, NJ. N. Woodford, A.P. Johnson (Eds.).
11. Oteo J., Cuevas O., Navarro C., Aracil B., Campos J. Spanish Group of The European Antimicrobial Resistance Surveillance System (EARSS). Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium. J Antimicrob Chemother 2007, 59:1044-1045.
12. Brown D.F., Hope R., Livermore D.M., et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(Suppl. 2):ii75-ii85.
13. Billström H., Lund B., Sullivan A., Nord C.E. Virulence and antimicrobial resistance in clinical Enterococcus faecium. Int J Antimicrob Agents 2008, 32:374-377.
14. Kaçmaz B., Aksoy A. Antimicrobial resistance of enterococci in Turkey. Int J Antimicrob Agents 2005, 25:535-538.
15. Werner G., Coque T.M., Hammerum A.M., et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008, 13. pii:19046.
16. Bonora M.G., Olioso D., Lo Cascio G., Fontana R. Phylogenetic analysis of vancomycin-resistant Enterococcus faecium genotypes associated with outbreaks or sporadic infections in Italy. Microb Drug Resist 2007, 13:171-177.
17. Willems R.J., Top J., van Santen M., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005, 11:821-828.